Lataa...
A small molecule inhibitor MCC950 ameliorates kidney injury in diabetic nephropathy by inhibiting NLRP3 inflammasome activation
BACKGROUND: Diabetic nephropathy (DN) is a lethal diabetic microvascular complication characterized by chronic low-grade inflammation. The NOD-like receptor pyrin domain-containing protein 3 (NLRP3) inflammasome is implicated in the progression of DN. MCC950 is a selective and potent inhibitor of NL...
Tallennettuna:
| Julkaisussa: | Diabetes Metab Syndr Obes |
|---|---|
| Päätekijät: | , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Dove
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6684489/ https://ncbi.nlm.nih.gov/pubmed/31447572 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DMSO.S199802 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|